InMed Pharmaceuticals (INM) SEC Filings & 10K Form

$0.23
-0.02 (-8.00%)
(As of 04/26/2024 ET)

Recent InMed Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/18/2024
12:30 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2024
1:39 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2024
10:26 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2024
12:44 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2024
2:20 PM
InMed Pharmaceuticals (Issuer)
MANCINI ALEXANDRA DIANE JANET (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
2:20 PM
HSU ERIC C (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
2:20 PM
HULL ANDREW (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
2:27 PM
InMed Pharmaceuticals (Issuer)
Jagpal Netta (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/22/2024
12:38 PM
HULL ANDREW (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
1:58 PM
ADAMS ERIC A (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
1:28 PM
ARMISTICE CAPITAL, LLC (Filed by)
InMed Pharmaceuticals (Subject)
Form SC 13G/A
02/09/2024
11:34 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/19/2024
1:33 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/16/2024
1:12 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2023
12:04 PM
HULL ANDREW (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
12:04 PM
InMed Pharmaceuticals (Issuer)
MANCINI ALEXANDRA DIANE JANET (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
12:05 PM
Baldasare Bryan T (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
12:07 PM
ADAMS ERIC A (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
12:07 PM
HSU ERIC C (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
12:08 PM
Grove Janet P (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
12:08 PM
InMed Pharmaceuticals (Issuer)
Tegge Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
12:09 PM
InMed Pharmaceuticals (Issuer)
WOUDENBERG MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
12:09 PM
InMed Pharmaceuticals (Issuer)
Lemerond Nicole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
12:09 PM
InMed Pharmaceuticals (Issuer)
Johnson Shane Aaron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2023
4:21 PM
InMed Pharmaceuticals (Filer)
Form 10-K/A
12/06/2023
8:02 AM
InMed Pharmaceuticals (Issuer)
WOUDENBERG MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2023
1:50 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
11:15 PM
InMed Pharmaceuticals (Filer)
Form EFFECT
11/13/2023
4:05 PM
InMed Pharmaceuticals (Filer)
Form 424B3
11/08/2023
4:05 PM
InMed Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
11/02/2023
1:56 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/27/2023
6:16 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/27/2023
3:08 PM
InMed Pharmaceuticals (Filer)
Form DEFA14A
10/24/2023
3:18 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/29/2023
4:18 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/29/2023
10:43 AM
InMed Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
09/29/2023
10:30 AM
InMed Pharmaceuticals (Filer)
Form NT 10-K
09/25/2023
3:12 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/22/2023
6:29 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/31/2023
4:22 PM
HSU ERIC C (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2023
3:26 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad)

If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)

Watch my video for all of the details
07/20/2023
1:18 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/22/2023
3:28 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/01/2023
12:27 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/25/2023
11:35 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/19/2023
12:41 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2023
4:58 PM
ADAMS ERIC A (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2023
4:59 PM
InMed Pharmaceuticals (Issuer)
MANCINI ALEXANDRA DIANE JANET (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2023
5:00 PM
HSU ERIC C (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2023
12:47 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2023
10:46 AM
InMed Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:INM) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners